Healthcare provider profile · identity verified

Scott C Clay, MD

Allopathic & Osteopathic Physicians|Family Medicine · BRUNSWICK, GA · NPI 1003901117

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Scott C Clay, MD received $174.33 in general payments during 2025 across 9 reported records.

Amgen Inc. accounted for 27.4% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 7 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Arexvy, Shingrix.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Arexvy by this doctor in 2024.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SHINGRIX as an associated drug or biological on 43515 records involving 26794 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Shingrix by this doctor in 2024.

GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Trelegy Ellipta by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$174.33

9 reported records · 5 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Amgen Inc.	Unresolved — no canonical attribution shown	$47.74	27.4%	3	2025
Insulet Corporation	Unresolved — no canonical attribution shown	$35.69	20.5%	2	2025
Saluda Medical Americas, Inc.	Unresolved — no canonical attribution shown	$34.72	19.9%	1	2025
GlaxoSmithKline, LLC.	Unresolved — no canonical attribution shown	$33.86	19.4%	2	2025
BIOTRONIK NRO, Inc.	Unresolved — no canonical attribution shown	$22.32	12.8%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$174.33	9

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
Omnipod Normalized: omnipod	Device	Insulet Corporation	$35.69	2	2025
Source payment records 2025-02-04 · Insulet Corporation · $15.14 · Open Payments source 2025-06-03 · Insulet Corporation · $20.55 · Open Payments source
Evoke Normalized: evoke	Device	Saluda Medical Americas, Inc.	$34.72	1	2025
Source payment records 2025-11-12 · Saluda Medical Americas, Inc. · $34.72 · Open Payments source
AREXVY Normalized: arexvy	Biological	GlaxoSmithKline, LLC.	$33.86	2	2025
Source payment records 2025-02-20 · GlaxoSmithKline, LLC. · $16.01 · Open Payments source 2025-05-29 · GlaxoSmithKline, LLC. · $17.85 · Open Payments source
SHINGRIX Normalized: shingrix	Biological	GlaxoSmithKline, LLC.	$33.86	2	2025
Source payment records 2025-02-20 · GlaxoSmithKline, LLC. · $16.01 · Open Payments source 2025-05-29 · GlaxoSmithKline, LLC. · $17.85 · Open Payments source
KRYSTEXXA Normalized: krystexxa	Biological	Amgen Inc.	$32.62	2	2025
Source payment records 2025-04-15 · Amgen Inc. · $16.63 · Open Payments source 2025-04-15 · Amgen Inc. · $15.99 · Open Payments source
Prospera Normalized: prospera	Device	BIOTRONIK NRO, Inc.	$22.32	1	2025
Source payment records 2025-11-04 · BIOTRONIK NRO, Inc. · $22.32 · Open Payments source
EVENITY Normalized: evenity	Biological	Amgen Inc.	$15.12	1	2025
Source payment records 2025-08-06 · Amgen Inc. · $15.12 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
AREXVY arexvy	2025	Arexvy	2024	14	exact normalized	Medicare Part D
SHINGRIX shingrix	2025	Shingrix	2024	25	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	AREXVY open payments reported associated product	CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445	Arexvy · 2024 Exact normalized brand match · 1 Part D row	14	14
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	SHINGRIX open payments reported associated product	CMS Open Payments — General Payments 43515 supporting records · 26794 recipient NPIs · example record 1190332452	Shingrix · 2024 Exact normalized brand match · 1 Part D row	25	17
GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference	2025	TRELEGY ELLIPTA open payments reported associated product	CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369	Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row	29	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	2361	206
Amlodipine Besylate	Amlodipine Besylate	1362	160
Levothyroxine Sodium	Levothyroxine Sodium	1241	141
Gabapentin	Gabapentin	1072	118
Furosemide	Furosemide	991	82
Famotidine	Famotidine	850	39
Pantoprazole Sodium	Pantoprazole Sodium	813	82
Eliquis	Apixaban	805	44
Potassium Chloride	Potassium Chloride	803	66
Omeprazole	Omeprazole	787	93
Donepezil Hcl	Donepezil Hcl	734	47
Losartan Potassium	Losartan Potassium	724	106
Trazodone Hcl	Trazodone Hcl	699	75
Metoprolol Tartrate	Metoprolol Tartrate	696	49
Escitalopram Oxalate	Escitalopram Oxalate	609	56
Tamsulosin Hcl	Tamsulosin Hcl	526	56
Montelukast Sodium	Montelukast Sodium	525	62
Rosuvastatin Calcium	Rosuvastatin Calcium	501	87
Memantine Hcl	Memantine Hcl	485	28
Metoprolol Succinate	Metoprolol Succinate	458	43
Sertraline Hcl	Sertraline Hcl	452	36
Citalopram Hbr	Citalopram Hydrobromide	416	39
Hydralazine Hcl	Hydralazine Hcl	416	37
Lisinopril	Lisinopril	414	52
Duloxetine Hcl	Duloxetine Hcl	402	42
Buspirone Hcl	Buspirone Hcl	398	37
Clopidogrel	Clopidogrel Bisulfate	398	36
Levetiracetam	Levetiracetam	398	20
Jardiance	Empagliflozin	362	33
Carvedilol	Carvedilol	340	33
Fluoxetine Hcl	Fluoxetine Hcl	339	26
Mirtazapine	Mirtazapine	335	30
Valsartan	Valsartan	322	63
Quetiapine Fumarate	Quetiapine Fumarate	300	25
Spironolactone	Spironolactone	233	26
Tramadol Hcl	Tramadol Hcl	232	48
Allopurinol	Allopurinol	228	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	223	30
Lorazepam	Lorazepam	221	37
Ozempic	Semaglutide	213	31
Fluticasone Propionate	Fluticasone Propionate	194	47
Divalproex Sodium	Divalproex Sodium	180	11
Simvastatin	Simvastatin	179	33
Meloxicam	Meloxicam	170	27
Hydrochlorothiazide	Hydrochlorothiazide	168	47
Metformin Hcl	Metformin Hcl	165	33
Pravastatin Sodium	Pravastatin Sodium	165	19
Clonidine Hcl	Clonidine Hcl	155	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	155	suppressed
Nifedipine Er	Nifedipine	154	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	144	23
Prednisone	Prednisone	142	22
Pregabalin	Pregabalin	134	21
Venlafaxine Hcl Er	Venlafaxine Hcl	134	12
Oxybutynin Chloride Er	Oxybutynin Chloride	126	suppressed
Risperidone	Risperidone	120	suppressed
Amiodarone Hcl	Amiodarone Hcl	119	suppressed
Topiramate	Topiramate	115	suppressed
Aripiprazole	Aripiprazole	114	suppressed
Paroxetine Hcl	Paroxetine Hcl	114	suppressed
Ranolazine Er	Ranolazine	114	suppressed
Baclofen	Baclofen	112	13
Bupropion Xl	Bupropion Hcl	112	28
Metformin Hcl Er	Metformin Hcl	110	27
Colchicine	Colchicine	108	11
Irbesartan	Irbesartan	107	16
Bisoprolol Fumarate	Bisoprolol Fumarate	106	11
Xarelto	Rivaroxaban	100	suppressed
Lactulose	Lactulose	98	28
Albuterol Sulfate Hfa	Albuterol Sulfate	94	42
Midodrine Hcl	Midodrine Hcl	91	suppressed
Albuterol Sulfate	Albuterol Sulfate	88	16
Clonazepam	Clonazepam	88	13
Labetalol Hcl	Labetalol Hcl	86	suppressed
Memantine Hcl Er	Memantine Hcl	85	suppressed
Warfarin Sodium	Warfarin Sodium	84	suppressed
Digoxin	Digoxin	83	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	82	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	82	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	79	13
Lamotrigine	Lamotrigine	77	suppressed
Ondansetron Hcl	Ondansetron Hcl	77	27
Primidone	Primidone	77	suppressed
Diclofenac Sodium	Diclofenac Sodium	74	34
Ropinirole Hcl	Ropinirole Hcl	73	11
Calcium Acetate	Calcium Acetate	71	suppressed
Lansoprazole	Lansoprazole	71	19
Farxiga	Dapagliflozin Propanediol	69	suppressed
Oxcarbazepine	Oxcarbazepine	69	suppressed
Mounjaro	Tirzepatide	68	13
Alendronate Sodium	Alendronate Sodium	67	17
Divalproex Sodium Er	Divalproex Sodium	67	suppressed
Latanoprost	Latanoprost	67	suppressed
Doxepin Hcl	Doxepin Hcl	66	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	63	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	63	suppressed
Myrbetriq	Mirabegron	63	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	13
Diltiazem 24hr Er	Diltiazem Hcl	62	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	62	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	61	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	60	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	12
Tizanidine Hcl	Tizanidine Hcl	59	11
Sevelamer Carbonate	Sevelamer Carbonate	58	suppressed
Ezetimibe	Ezetimibe	57	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	57	suppressed
Tradjenta	Linagliptin	56	suppressed
Breo Ellipta	Fluticasone/Vilanterol	51	14
Brilinta	Ticagrelor	51	suppressed
Cilostazol	Cilostazol	51	suppressed
Oxycodone Hcl	Oxycodone Hcl	51	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	51	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	50	suppressed
Lacosamide	Lacosamide	49	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	48	suppressed
Clonidine	Clonidine	48	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	suppressed
Alprazolam	Alprazolam	45	suppressed
Entresto	Sacubitril/Valsartan	45	suppressed
Linzess	Linaclotide	45	suppressed
Finasteride	Finasteride	44	15
Azithromycin	Azithromycin	43	40
Isosorbide Dinitrate	Isosorbide Dinitrate	43	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	43	suppressed
Calcitriol	Calcitriol	42	suppressed
Olanzapine	Olanzapine	42	suppressed
Verapamil Hcl	Verapamil Hcl	42	suppressed
Cephalexin	Cephalexin	41	33
Diazepam	Diazepam	41	suppressed
Trulicity	Dulaglutide	41	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	40	suppressed
Benztropine Mesylate	Benztropine Mesylate	39	suppressed
Meclizine Hcl	Meclizine Hcl	39	suppressed
Azelastine Hcl	Azelastine Hcl	38	15
Methylprednisolone	Methylprednisolone	38	36
Atenolol	Atenolol	37	12
Nyamyc	Nystatin	37	13
Mesalamine Dr	Mesalamine	36	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	36	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	31
Mitigare	Colchicine	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	19
Haloperidol	Haloperidol	34	suppressed
Lovastatin	Lovastatin	34	suppressed
Methocarbamol	Methocarbamol	34	20
Hydroxyurea	Hydroxyurea	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Ceftriaxone	Ceftriaxone Sodium	31	19
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	14
Estradiol	Estradiol	31	suppressed
Ipratropium Bromide	Ipratropium Bromide	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	29	suppressed
Hydrocortisone	Hydrocortisone	29	suppressed
Ketoconazole	Ketoconazole	29	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	24
Timolol Maleate	Timolol Maleate	29	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	27	suppressed
Armodafinil	Armodafinil	26	suppressed
Fentanyl	Fentanyl	26	suppressed
Cefdinir	Cefdinir	25	23
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	25	17
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	24	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Telmisartan	Telmisartan	24	suppressed
Insulin Lispro	Insulin Lispro	23	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	23	suppressed
Fluconazole	Fluconazole	22	17
Januvia	Sitagliptin Phosphate	22	suppressed
Metolazone	Metolazone	22	suppressed
Movantik	Naloxegol Oxalate	22	suppressed
Nystatin	Nystatin	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Nitroglycerin	Nitroglycerin	21	17
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Novolin R	Insulin Regular, Human	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	11
Verapamil Er	Verapamil Hcl	18	suppressed
Prazosin Hcl	Prazosin Hcl	17	suppressed
Tresiba	Insulin Degludec	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Constulose	Lactulose	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Insulin Aspart	Insulin Aspart	15	suppressed
Nystop	Nystatin	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	14
Valproic Acid	Valproic Acid (As Sodium Salt)	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Arexvy	Rsvpref3 Antigen/As01e/Pf	14	14
Chlorthalidone	Chlorthalidone	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Premarin	Estrogens, Conjugated	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Amoxicillin	Amoxicillin	13	12
Bupropion Hcl	Bupropion Hcl	13	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Jantoven	Warfarin Sodium	13	suppressed
Levofloxacin	Levofloxacin	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Aliskiren	Aliskiren Hemifumarate	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Etodolac	Etodolac	12	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Invokana	Canagliflozin	12	suppressed
Levetiracetam Er	Levetiracetam	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Mirabegron Er	Mirabegron	12	suppressed
Savella	Milnacipran Hcl	12	suppressed
Travoprost	Travoprost	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	11	suppressed
Fiasp	Insulin Aspart (Niacinamide)	11	suppressed
Gemtesa	Vibegron	11	suppressed
Haloperidol Lactate	Haloperidol Lactate	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$174.33 · 9 records	Amgen Inc.	AREXVY, EVENITY, Evoke, KRYSTEXXA, Omnipod, Prospera, SHINGRIX	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Arexvy play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error